MedTrace Logo

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

NCT04153305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1010

Last updated 2023-01-11

No results posted yet for this study

Summary

The Fondazione per la Ricerca Ospedale di Bergamo (FROM) decided to propose and promote the completion of ERNEST registry: the aim of the project is to obtain up-to-date estimates of clinical outcome of these patients in primary and secondary Myelofibrosis that have been included in the 'original' ERNEST study. The last was conducted between 2012 and beginning of 2015 including 1292 patients with Myelofibrosis, but it was interrupted in 2015 because of bankruptcy of the previous sponsor.

Conditions

Sponsors & Collaborators

  • FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

    lead OTHER

Principal Investigators

  • Tiziano Barbui, MD · Fondazione per la Ricerca Ospedale di Bergamo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-08
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Italy
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04153305 on ClinicalTrials.gov